Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 51407-803

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 51407-803). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-799-60 (Quetiapine ER.jpg)

Label for Quetiapine Extended Release Tablets USP 50 mg oral tablets in a 60-count package by GSMS, Incorporated. The label includes the NDC number 51407-799-60, directions to take once daily, and storage instructions. It also states the active content as 57.56 mg quetiapine fumarate equivalent to 50 mg quetiapine and contains warnings to keep out of reach of children and not to split, crush, or chew the tablets.*

FDA Label Image

51407-800-60 (Quetiapine ER.jpg)

Label for Quetiapine Extended-Release Tablets, USP 150 mg film-coated tablets by Golden State Medical Supply, Inc. The label shows dosage strength 150 mg and instructions indicating once daily use. The package contains 60 tablets, with an NDC of 51407-800-60. It includes warnings on storage and medication handling, plus a barcode and manufacturer address.*

FDA Label Image

51407-801-60 (Quetiapine ER.jpg)

Label for Quetiapine Extended-Release Tablets USP 200 mg by Golden State Medical Supply, Inc. The label includes NDC 51407-801-60, dosage instructions as once daily, package quantity of 60 tablets, and pharmacist instructions to dispense the medication guide. Storage and handling guidelines are also provided, including temperature conditions.*

FDA Label Image

51407-802-60ol (Quetiapine ER.jpg)

Label for Quetiapine Extended Release Tablets, USP 300 mg oral tablets by Golden State Medical Supply, Inc. The label indicates a 60-tablet count with prescription only. It includes dosing instructions of once daily, storage temperature guidelines, and cautions to keep out of reach of children. The label references queitapine fumarate equivalent to 300 mg quetiapine per tablet.*

FDA Label Image

51407-803-60ol (Quetiapine ER.jpg)

Label for Quetiapine Extended-Release Tablets USP, 400 mg, oral dosage form, with a package size of 60 tablets. The label includes NDC 51407-803-60 and instructions for pharmacists to dispense a Medication Guide. Marketed by GSMS Incorporated, Camarillo, CA, the label states storage conditions and usage directions such as 'Once Daily' and 'swallow whole, do not split, crush, or chew.'*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Fig01)

A line graph showing the proportion of patients with relapse (%) over time (months) comparing PLA (placebo) and QTP XR (Quetiapine Extended Release). The y-axis represents relapse proportion from 0 to 100%, and the x-axis represents time in months from 0 to 7. The graph includes stepwise curves depicting the relapse rates for both groups.*

FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Fig02)

A Kaplan-Meier curve chart showing the proportion of patients with relapse (%) over time in weeks. The chart compares two groups: one treated with CTP plus LIVAL, and the other with PLA plus LIVAL, tracking relapse rates up to 100 weeks.*

FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Fig03)

A line chart showing the proportion of patients with relapse (%) over time (weeks) for two groups labeled QTP+LIVAL and PLA+LIVAL. The chart has a vertical axis for proportion (0-100%) and a horizontal axis for time up to 100 weeks, illustrating relapse rates across the study period.*

FDA Label Image

Structural Formula (Quetiapine Str)

Chemical structure diagram of Quetiapine, the active ingredient in Quetiapine Extended Release tablets by Golden State Medical Supply, Inc. The structure includes two Quetiapine molecules and an associated salt moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.